Cancer Care Ontario | Cancer Care Ontario

183 Results

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2024

Status: Current
ID: PET 2024-1

Updated

Mar 2025

Guidelines and Advice

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

Status: Current
ID: Guideline Endorsement C50-CIDAP-3

Updated

Mar 2025

Guidelines and Advice

The Use of Molecular Tools for Identifying and Guiding Treatment of Cancers of Unknown Primary

Status: Current
ID: MOTAC-7

Jan 2025

Guidelines and Advice

Ontario Cervical Screening Program: Interim guidance to support the transition years following the launch of human papillomavirus testing in Ontario: Cervical screening and colposcopy recommendations for people ages 21 to 24

Status: Current

Updated

Mar 2025

Guidelines and Advice

Follow-up for Cervical Cancer

Status: Current
ID: 4-16
Version: 2

Updated

May 2025

Guidelines and Advice

Ontario Cervical Screening Program recommendations for cervical screening and colposcopy with human papillomavirus testing in Ontario

Updated

Mar 2025

Guidelines and Advice

T-Cell Engaging Antibodies: Management of Cytokine Release Syndrome (CRS) and Immune Effector-Associated Neurotoxicity Syndrome (ICANS)

Status: Current

Updated

Mar 2025

Guidelines and Advice

Ontario Cervical Screening Program: Guidance for Vaginal Vault Testing

Status: Current

Updated

Mar 2025

Guidelines and Advice

Postmastectomy Breast Reconstruction in Patients with Non-Metastatic Breast Cancer

Status: Current
ID: GL 17-10 v2
Version: 2

Updated

Mar 2025

Guidelines and Advice

Effective Teaching Strategies and Methods for Cancer Patient Education

Status: Current
ID: GL 20-2
Version: 2

Updated

Apr 2025

Regimen

ATEZ(MNT)

Cancer Type:

Lung,

Small Cell

Show More Show more tags

, Show Less Show fewer tags

Intent: Palliative

Funding:

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

Show More Show more tags

, Show Less Show fewer tags

Drugs Used:

atezolizumab,

atezolizumab (subcut)

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Jun 2025

Regimen

CISPETOP+ATEZ

Cancer Type:

Lung,

Small Cell

Show More Show more tags

, Show Less Show fewer tags

Intent: Palliative

Funding:

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

Show More Show more tags

, Show Less Show fewer tags

Drugs Used:

atezolizumab,

atezolizumab (subcut),

CISplatin,

etoposide

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

May 2025

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2024

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

The Use of Molecular Tools for Identifying and Guiding Treatment of Cancers of Unknown Primary

Ontario Cervical Screening Program: Interim guidance to support the transition years following the launch of human papillomavirus testing in Ontario: Cervical screening and colposcopy recommendations for people ages 21 to 24

Follow-up for Cervical Cancer

Ontario Cervical Screening Program recommendations for cervical screening and colposcopy with human papillomavirus testing in Ontario

T-Cell Engaging Antibodies: Management of Cytokine Release Syndrome (CRS) and Immune Effector-Associated Neurotoxicity Syndrome (ICANS)

Ontario Cervical Screening Program: Guidance for Vaginal Vault Testing

Postmastectomy Breast Reconstruction in Patients with Non-Metastatic Breast Cancer

Effective Teaching Strategies and Methods for Cancer Patient Education

ATEZ(MNT)

CISPETOP+ATEZ

Pages